Pennant Group, Inc. (PNTG) company profile
Close on Nov 17, 2026Market cap $1.27BP/E 40.6Yield –
About Pennant
Services-Health Services, SIC 8000
The Pennant Group, Inc. provides healthcare and residential services to patients, residents, and clients across the United States. Its operations comprise two reportable segments: home health and hospice services, and senior living services. Through these divisions, the organization delivers home health clinical care—such as skilled nursing, therapy, medical social work, and home health aides—alongside palliative care, personal home care, and hospice support for terminally ill individuals. In addition, it operates residential communities offering assisted living, independent living, and memory care, delivering housing, housekeeping, meals, and assistance with daily routines. The company caters to individuals of all ages, with an emphasis on aging adults, deriving revenue from Medicare, Medicaid, managed care organizations, and private payers.
As of December 31, 2025, the organization conducts business across 16 states, including Alabama, Arizona, California, Colorado, Georgia, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming, with additional management support provided in Connecticut. Its scale includes 172 home health and hospice agencies and 63 senior living communities containing 4,428 units. The excerpt does not disclose the location of the corporate headquarters.
Summary of the business section of Pennant's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Pennant Group, Inc.
- Founded
- 2019
- Headquarters
- Eagle, ID
- Address
- 1675 E. Riverside Drive 83616
- Phone
- (208) 401-1400
- Website
- pennantgroup.com
- Employees
- 9,700, Dec 31, 2025
- Industry
- Services-Health Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- DELOITTE & TOUCHE LLP, Boise, ID
Stock & identifiers
- Ticker
- PNTG
- Exchange
- Nasdaq
- IPO date
- Oct 1, 2019
- Shares outstanding
- 35M, Aug 3, 2026
- Public float
- $989.44M, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1766400
- CUSIP
- 70805E109
- ISIN
- US70805E1091
- FIGI
- BBG00P33SY72
- Share class FIGI
- BBG00P33SZ15
- LEI
- 5493007H2OYR6BYLDA64
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| John J. Gochnour | Chief Operating Officer | 144,788 |
| Brent Guerisoli | Chief Executive Officer | 99,544 |
| Jason Paul Steik | Chief Clinical Officer | 15,106 |
| Kirk Sterling Cheney | EVP, GC and Corp Secy | 18,401 |
| Lynette Walbom | Chief Financial Officer | 10,688 |
| Barry M. Smith | Director | 99,299 |
| Gregory K. Morris Sr. | Director | 39,200 |
| John G. Nackel | Director | 179,165 |
| Scott E. Lamb | Director | 61,335 |
| Suzanne D. Snapper | Director | 232,264 |
| Christopher R. Christensen | Director | 771,238 |
| Stephen M. R. Covey | Director | 45,950 |
| JoAnne Stringfield | Director | 30,275 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $3.74M | $2.97M | $2.42M | $48 | $98 |
| FY2024 Brent J.Guerisoli | $2.59M | $4.50M | $1.40M | $46 | $95 |
| FY2024 Guerisoli | $2.59M | $4.50M | $1.40M | $46 | $95 |
| FY2023 | $1.87M | $2.39M | $820.65K | $24 | $96 |
| FY2023 Brent J.Guerisoli | $1.87M | $2.39M | $820.65K | $24 | $96 |
| FY2023 Guerisoli | $1.87M | $2.39M | $820.65K | $24 | $96 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|---|
| Brent J. Guerisoli Chief Executive Officer | $444.71K | – | $662.12K | $885.59K | $1.74M | $9.19K | $3.74M | +44% |
| Lynette B. Walbom Chief Financial Officer | $338.65K | – | $471.92K | $664.19K | $1.18M | $7.61K | $2.66M | +66% |
| John J. Gochnour President and Chief Operating Officer | $369.71K | – | $613.02K | $811.79K | $1.59M | $10.19K | $3.39M | +65% |
| Kirk S. Cheney EVP, General Counsel and Corporate Secretary | $285.87K | $500.00K | $134.89K | $516.59K | $365.10K | $283 | $1.80M | +89% |
| Jason P. Steik Chief Clinical Officer | $283.65K | $1.03M | – | $516.59K | – | $1.77K | $1.83M | +81% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 9,700 employees who were employed by our independent operating subsidiaries or our Service Center.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 2, 2025 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jan 2, 2025 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Oct 3, 2019 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| May 6, 2019 | Spin-off | Registration as a new public company (Form 10), e.g. spin-off |
See a number that looks wrong?